These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2561877)

  • 61. In vivo and in vitro 31P magnetic resonance spectroscopy of focal hepatic malignancies.
    Cox IJ; Bell JD; Peden CJ; Iles RA; Foster CS; Watanapa P; Williamson RC
    NMR Biomed; 1992; 5(3):114-20. PubMed ID: 1322688
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Magnetic resonance tomography of focal hepatic lesions using the para-magnetic contrast medium, gadolinium DTPA. First clinical results].
    Hamm B; Römer T; Felix R; Wolf KJ
    Rofo; 1986 Dec; 145(6):684-91. PubMed ID: 3025957
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Quantitative proton magnetic resonance spectroscopy of the normal liver and malignant hepatic lesions at 3.0 Tesla.
    Fischbach F; Schirmer T; Thormann M; Freund T; Ricke J; Bruhn H
    Eur Radiol; 2008 Nov; 18(11):2549-58. PubMed ID: 18491103
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Comparative vasographic and scintigraphic studies in liver tumors].
    Düx A; Winkler C; Esser G; Bücheler E
    Fortschr Geb Rontgenstr Nuklearmed; 1967 Apr; 106(4):502-24. PubMed ID: 4297351
    [No Abstract]   [Full Text] [Related]  

  • 65. Differentiation between cavernous hemangiomas and untreated malignant neoplasms of the liver with free-breathing diffusion-weighted MR imaging: comparison with T2-weighted fast spin-echo MR imaging.
    Soyer P; Corno L; Boudiaf M; Aout M; Sirol M; Placé V; Duchat F; Guerrache Y; Fargeaudou Y; Vicaut E; Pocard M; Hamzi L
    Eur J Radiol; 2011 Nov; 80(2):316-24. PubMed ID: 20800983
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The response of the rat liver in situ to bromobenzene--in vivo proton magnetic resonance imaging and 31P magnetic resonance spectroscopy studies.
    Locke SJ; Brauer M
    Toxicol Appl Pharmacol; 1991 Sep; 110(3):416-28. PubMed ID: 1949010
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [New methods, new diseases; benign liver tumors].
    van der Heyde MN; Brandt KH; Bronkhorst FB; Kesselring FO
    Ned Tijdschr Geneeskd; 1985 Jun; 129(24):1121-3. PubMed ID: 2991780
    [No Abstract]   [Full Text] [Related]  

  • 68. In vivo 1H magnetic resonance spectroscopy in evaluation of hepatocellular carcinoma and its early response to transcatheter arterial chemoembolization.
    Wu B; Peng WJ; Wang PJ; Gu YJ; Li WT; Zhou LP; Tang F; Zhong GM
    Chin Med Sci J; 2006 Dec; 21(4):258-64. PubMed ID: 17249202
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Diagnosis of coexistent hepatic tumors of different kinds: a challenge from CT and MR imaging.
    Itai Y; Ohtomo K; Kokubo T; Yoshida H; Minami M; Kawauchi N; Okada Y
    Radiat Med; 1989; 7(3):143-9. PubMed ID: 2555846
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Characterization of the spleen by in vivo image guided 31P magnetic resonance spectroscopy.
    Smith SR; Martin PA; Davies JM; Edwards RH
    NMR Biomed; 1989 Nov; 2(4):172-8. PubMed ID: 2641499
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Adult hepatic cavernous haemangioma with highly elevated alpha-fetoprotein.
    Han SL; Wu XL; Jia ZR; Wang PF
    Hong Kong Med J; 2010 Oct; 16(5):400-2. PubMed ID: 20890007
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Small hepatocellular carcinoma and cavernous hemangioma: differentiation with dynamic FLASH MR imaging with Gd-DTPA.
    Yoshida H; Itai Y; Ohtomo K; Kokubo T; Minami M; Yashiro N
    Radiology; 1989 May; 171(2):339-42. PubMed ID: 2539606
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Potential MR pitfall in relying on lesion/liver intensity ratio in presence of hepatic hemochromatosis.
    Mirowitz S; Heiken JP; Lee JK
    J Comput Assist Tomogr; 1988; 12(2):323-4. PubMed ID: 3351049
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cavernous hemangioma of the liver: assessment of MR tissue specificity with a simplified T2 index.
    Mirowitz SA; Lee JK; Heiken JP
    J Comput Assist Tomogr; 1990; 14(2):223-8. PubMed ID: 2312850
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Preoperative segmental localization of focal hepatic lesion on MRI.
    Chen Z; Su X; Ouyang H; Meng T; Yuan X; Shao Y
    Chin Med Sci J; 1995 Sep; 10(3):169-73. PubMed ID: 8580488
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A comparison of in vivo and in vitro 31P NMR spectra from human breast tumours: variations in phospholipid metabolism.
    Smith TA; Glaholm J; Leach MO; Machin L; Collins DJ; Payne GS; McCready VR
    Br J Cancer; 1991 Apr; 63(4):514-6. PubMed ID: 2021535
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A study of T1-weighted 31phosphorus MR-spectroscopy from patients with focal and diffuse liver disease.
    Brinkmann G; Melchert UH
    Magn Reson Imaging; 1992; 10(6):949-56. PubMed ID: 1461092
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mucinous carcinoma of the liver mimicking cavernous hemangioma on pre- and postcontrast MR imaging.
    Ueda K; Matsui O; Nobata K; Takashima T
    AJR Am J Roentgenol; 1996 Feb; 166(2):468-9. PubMed ID: 8553980
    [No Abstract]   [Full Text] [Related]  

  • 79. Liver tumors: follow-up with P-31 MR spectroscopy after local chemotherapy and chemoembolization.
    Schilling A; Gewiese B; Berger G; Boese-Landgraf J; Fobbe F; Stiller D; Gallkowski U; Wolf KJ
    Radiology; 1992 Mar; 182(3):887-90. PubMed ID: 1311119
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Diagnosis and surgical treatment of primary and secondary solid hepatic tumors in the adult.
    Adson MA
    Surg Clin North Am; 1981 Feb; 61(1):181-96. PubMed ID: 6259765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.